PMC:7271924 / 24124-24331 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T475","span":{"begin":15,"end":28},"obj":"GO:0050817"},{"id":"T476","span":{"begin":64,"end":71},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T477","span":{"begin":110,"end":117},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T478","span":{"begin":183,"end":191},"obj":"SP_7"},{"id":"T76458","span":{"begin":15,"end":28},"obj":"GO:0050817"},{"id":"T46556","span":{"begin":64,"end":71},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T17255","span":{"begin":110,"end":117},"obj":"CHEBI:24505;CHEBI:24505"},{"id":"T12103","span":{"begin":183,"end":191},"obj":"SP_7"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T1","span":{"begin":64,"end":71},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T2","span":{"begin":64,"end":71},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"},{"id":"T3","span":{"begin":110,"end":117},"obj":"https://glytoucan.org/Structures/Glycans/G00021MO"},{"id":"T4","span":{"begin":110,"end":117},"obj":"https://glytoucan.org/Structures/Glycans/G54161DR"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"612","span":{"begin":192,"end":200},"obj":"Species"},{"id":"613","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"614","span":{"begin":89,"end":117},"obj":"Chemical"},{"id":"635","span":{"begin":183,"end":191},"obj":"Disease"}],"attributes":[{"id":"A612","pred":"tao:has_database_id","subj":"612","obj":"Tax:9606"},{"id":"A613","pred":"tao:has_database_id","subj":"613","obj":"MESH:D006493"},{"id":"A614","pred":"tao:has_database_id","subj":"614","obj":"MESH:D006495"},{"id":"A635","pred":"tao:has_database_id","subj":"635","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T291","span":{"begin":64,"end":71},"obj":"Body_part"},{"id":"T292","span":{"begin":110,"end":117},"obj":"Body_part"}],"attributes":[{"id":"A291","pred":"fma_id","subj":"T291","obj":"http://purl.org/sig/ont/fma/fma82839"},{"id":"A292","pred":"fma_id","subj":"T292","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T80","span":{"begin":183,"end":191},"obj":"Disease"}],"attributes":[{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T308","span":{"begin":15,"end":28},"obj":"Chemical"},{"id":"T309","span":{"begin":64,"end":71},"obj":"Chemical"},{"id":"T310","span":{"begin":110,"end":117},"obj":"Chemical"}],"attributes":[{"id":"A308","pred":"chebi_id","subj":"T308","obj":"http://purl.obolibrary.org/obo/CHEBI_50249"},{"id":"A309","pred":"chebi_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"},{"id":"A310","pred":"chebi_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T186","span":{"begin":0,"end":207},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"MyTest","denotations":[{"id":"32574271-32220112-34514738","span":{"begin":202,"end":205},"obj":"32220112"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"TEST0","denotations":[{"id":"32574271-202-209-2882330","span":{"begin":202,"end":205},"obj":"[\"32220112\"]"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}

{"project":"2_test","denotations":[{"id":"32574271-32220112-34514738","span":{"begin":202,"end":205},"obj":"32220112"}],"text":"Interestingly, anticoagulant therapy, mainly with (intravenous) heparin (and mainly with low molecular weight heparin, LMWH), appears to be associated with better prognosis in severe COVID-19 patients (179)."}